Oligodendrocyte progenitor cell
Oligodendrocyte progenitor cell
| Cell information | |
|---|---|
| System | |
| Function | Precursor to oligodendrocytes |
| Location | |
| Origin | |
| Precursor | |
| Gives rise to | |
Oligodendrocyte progenitor cells (OPCs) are a type of neuroglia (glial cell) in the central nervous system (CNS). They are the precursors to oligodendrocytes, which are responsible for the formation of myelin sheaths around neurons in the CNS.
Function[edit]
OPCs play a crucial role in the development and maintenance of the CNS. They are involved in the process of myelination, which is essential for the proper functioning of the nervous system. Myelination increases the speed at which electrical impulses propagate along the axon of a neuron.
Development[edit]
OPCs originate from the neural tube during embryonic development. They migrate throughout the CNS and differentiate into oligodendrocytes in response to various growth factors and signaling pathways.
Clinical significance[edit]
OPCs are of significant interest in neuroscience and neurology due to their potential role in neurodegenerative diseases and demyelinating disorders such as multiple sclerosis. Research is ongoing to explore the potential of OPCs in regenerative medicine and cell therapy for repairing damaged myelin.
Research[edit]
Studies have shown that OPCs can be influenced by various extracellular signals to either proliferate or differentiate. Understanding these signals is key to developing therapies for diseases involving myelin damage.
See also[edit]
References[edit]
External links[edit]
- Oligodendrocyte progenitor cell on WikiMD
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian